Thiamine for Beriberi and Cardiac Failure

Beriberi is the syndrome of severe thiamine deficiency outside the brain, classically described in three forms: dry beriberi (length-dependent symmetric peripheral polyneuropathy), wet beriberi (high-output congestive heart failure with peripheral edema), and shoshin (acute fulminant cardiovascular collapse with lactic acidosis, often fatal within hours if thiamine is not given parenterally). Historically a disease of Asian rice-polishing populations, beriberi now appears in chronic alcoholics, dialysis patients, hyperemesis gravidarum, post-bariatric surgery, infants of thiamine-deficient mothers, and any patient on prolonged parenteral nutrition without thiamine. The cardiac response to parenteral thiamine is one of the most dramatic in medicine — ejection fraction improves measurably within 24-48 hours, edema clears within days, and the diagnosis is often confirmed by the magnitude and speed of the response. This page covers the three clinical phenotypes, the historical discovery, modern presentations, the biochemical fingerprint (lactic acidosis with high cardiac output), and the parenteral protocol.

Table of Contents

1. What Beriberi Is
2. The Three Clinical Forms
3. Dry Beriberi (Peripheral Polyneuropathy)
4. Wet Beriberi (High-Output Heart Failure)
5. Shoshin (Acute Fulminant Cardiac Beriberi)
6. Historical Discovery: Takaki and Eijkman
7. Modern Causes
8. The Biochemistry of Cardiac Failure in Thiamine Deficiency
9. Diagnosis
10. Treatment Protocol
11. Response Timeline
12. Heart Failure Patients on Loop Diuretics
13. Cautions
14. Key Research Papers
15. Connections

What Beriberi Is

Beriberi is the clinical syndrome of severe thiamine deficiency outside the central nervous system. The name comes from the Sinhalese word beri (meaning "weakness," repeated for emphasis), reflecting the profound muscular weakness and exhaustion that characterizes the disease. While Wernicke-Korsakoff syndrome affects the brain, beriberi affects predominantly the peripheral nerves and the heart, though in practice they often coexist because the same patient with the same dietary deficiency manifests both at once.

Beriberi was epidemic across rice-eating populations of East and Southeast Asia from the late 1800s through the 1930s, following the introduction of steam-powered rice mills that produced highly polished white rice stripped of its thiamine-rich outer bran. Naval seamen, prison populations, and rural laborers fed near-exclusively on polished rice developed beriberi by the thousands, and the disease was for decades thought to be infectious. The discovery in the 1880s-1920s that beriberi was caused by absence of a dietary factor (later identified as vitamin B1) was a landmark in the development of the nutritional sciences and led to two Nobel Prizes.

The disease is now rare in high-income countries but is far from extinct. It appears in chronic alcoholics, patients on prolonged parenteral nutrition without thiamine, dialysis patients, hyperemesis gravidarum, post-bariatric surgery, and in refugee and famine populations. Outbreaks have been reported in immigration detention facilities, on commercial fishing vessels, and in any setting where a homogeneous low-thiamine diet is consumed for weeks to months.

Back to Table of Contents

The Three Clinical Forms

Classical descriptions divide beriberi into three forms based on which tissue dominates the clinical picture, though in practice patients often have overlapping features:

• Dry beriberi — predominantly a symmetric peripheral polyneuropathy. Cardiac involvement is absent or minor. The disease progresses over weeks to months.
• Wet beriberi — a high-output congestive heart failure with peripheral edema. Peripheral neuropathy is often present but the cardiac picture dominates. Progresses over weeks.
• Shoshin beriberi — the acute fulminant form. Patients present in cardiogenic shock with severe lactic acidosis. Without parenteral thiamine, death occurs within hours to days. The name shoshin is Japanese for "acute damage of the heart."

A fourth entity, infantile beriberi, occurs in breastfed infants of thiamine-deficient mothers and historically caused enormous infant mortality in Asia. It presents acutely with cardiac failure, aphonia (an inability to cry), and seizures, and is rapidly fatal without thiamine. The condition has reappeared sporadically — a 2003 outbreak in Israel was traced to a defective soy-based infant formula in which thiamine had degraded.

Back to Table of Contents

Dry Beriberi (Peripheral Polyneuropathy)

Dry beriberi is a symmetric, length-dependent, axonal sensorimotor polyneuropathy with prominent autonomic involvement. The typical presentation includes:

• Distal symmetric sensory loss — numbness, tingling, and burning in a stocking-glove distribution, starting in the feet and ascending
• Motor weakness — foot drop, calf weakness, and difficulty climbing stairs; in advanced cases, hand weakness and muscle wasting
• Loss of deep tendon reflexes — ankle reflexes absent early, knee reflexes lost later
• Autonomic features — orthostatic hypotension, gastroparesis, constipation, impaired sweating
• Painful cramps — particularly nocturnal calf cramps and burning foot pain

The differential diagnosis is broad and includes diabetic peripheral neuropathy, alcoholic neuropathy (which itself includes a thiamine-deficiency component), and other nutritional neuropathies. In practice, severe alcoholic neuropathy is largely a beriberi-equivalent picture with overlapping toxic and nutritional mechanisms.

Nerve conduction studies show axonal loss with reduced amplitudes and relatively preserved conduction velocities. Sural nerve biopsy (rarely needed) shows axonal degeneration with secondary myelin loss.

Treatment is parenteral thiamine, but neurological recovery is slower than cardiac recovery. Sensory symptoms often improve over weeks to months. Motor strength returns gradually as axons regenerate (1-2 mm per day from the proximal site of injury). Severe cases may have residual deficits even with optimal treatment, particularly if treatment is delayed.

Back to Table of Contents

Wet Beriberi (High-Output Heart Failure)

Wet beriberi is a unique form of cardiac failure that is high-output rather than low-output. The biochemistry: severe thiamine deficiency causes peripheral vasodilation (the mechanism is incompletely understood but likely involves accumulated metabolic acids and impaired smooth muscle metabolism), and the heart compensates by increasing cardiac output to maintain blood pressure. Over time, the high-output state exhausts the cardiac reserve and the heart begins to fail despite an elevated ejection fraction.

Clinical features:

• Marked peripheral edema — bilateral leg swelling, often with anasarca in severe cases
• Tachycardia — resting heart rate typically 100-130 bpm
• Bounding peripheral pulses — reflecting the high cardiac output and warm vasodilated periphery
• Wide pulse pressure — systolic minus diastolic often >60 mmHg
• Dyspnea on exertion progressing to dyspnea at rest
• Right heart failure features — elevated jugular venous pressure, hepatic congestion, ascites in advanced cases
• Often preserved ejection fraction on echocardiography — the heart is failing functionally but the systolic squeeze appears normal or hyperdynamic
• Lactic acidosis on labs — the biochemical fingerprint

The combination of high-output heart failure + lactic acidosis + a normal or hyperdynamic ejection fraction in a malnourished, alcoholic, or otherwise high-risk patient should prompt immediate parenteral thiamine. The differential diagnosis includes other causes of high-output heart failure (severe anemia, hyperthyroidism, arteriovenous fistulae, sepsis) but the response to thiamine is so rapid and dramatic that it often confirms the diagnosis empirically.

Note the contrast with the more common low-output heart failure seen in conventional cardiology practice (reduced ejection fraction, narrow pulse pressure, cool peripheries, low cardiac output). Wet beriberi is the mirror image and is often missed because clinicians do not expect this presentation.

Back to Table of Contents

Shoshin (Acute Fulminant Cardiac Beriberi)

Shoshin is the most dramatic and most rapidly fatal form. The Japanese term means "acute damage of the heart" and was used to describe the catastrophic, hours-to-days fatal cardiovascular collapse seen in some severely thiamine-deficient patients. Modern presentations include:

• An alcoholic or otherwise high-risk patient presenting to the emergency department in cardiogenic shock
• Severe lactic acidosis — lactate often >10 mmol/L
• Hypotension with paradoxically warm, well-perfused extremities (the high-output failure pattern persisting into cardiovascular collapse)
• Marked tachycardia with a hyperdynamic precordium
• Echocardiography showing either hyperdynamic LV function with high cardiac output or, in late stages, biventricular dilatation and dysfunction
• Standard heart-failure therapy (diuretics, vasopressors) making the patient worse — this is a useful clinical pearl, because the appropriate treatment is the opposite of what is given in conventional cardiogenic shock

Without parenteral thiamine, shoshin is rapidly fatal. With thiamine, the response is among the most dramatic in medicine: cardiac output often falls toward normal within hours, lactate clears, ejection fraction normalizes within days, and patients who looked moribund can walk out of the hospital within a week. Any unexplained cardiogenic shock with profound lactic acidosis in a high-risk patient warrants empiric thiamine 500 mg IV before further workup.

Back to Table of Contents

Historical Discovery: Takaki and Eijkman

The discovery that beriberi was caused by absence of a dietary factor (rather than by infection or toxin) is one of the foundational stories in nutrition science. Two key figures share the credit:

Kanehiro Takaki, a Japanese naval physician, observed in the 1880s that beriberi was crippling the Imperial Japanese Navy — thousands of seamen developed the disease on long voyages, and the case-fatality was high. Takaki noted that British sailors on similar voyages did not develop beriberi, and hypothesized that the difference was in the diet: Japanese sailors ate near-exclusively polished rice, while British sailors ate a mixed diet of meat, bread, and vegetables. In an experimental voyage in 1884, he provisioned the warship Tsukuba with a Western-style diet including meat, condensed milk, vegetables, and barley-supplemented rice. The crew had no cases of beriberi, while a control voyage on polished rice produced 169 cases including 25 deaths. Takaki incorrectly attributed the protection to protein content, but he had nonetheless proven beriberi was diet-related.

Christiaan Eijkman, a Dutch military physician working in the Dutch East Indies (modern Indonesia), made the next critical observation in the 1890s. He was investigating beriberi in chicken coops at his Jakarta laboratory and observed that chickens developed a beriberi-like polyneuritis when fed white polished rice but recovered when fed brown rice or rice husks. His associate Gerrit Grijns correctly interpreted the finding: polished rice was missing a substance present in the bran that was essential for nerve health. The substance was eventually isolated by Casimir Funk in 1911 and named "vitamine" — from "vital amine" — coining the word that became "vitamin."

Eijkman shared the 1929 Nobel Prize in Physiology or Medicine with Frederick Hopkins for the discovery of vitamins. The Asian rice-polishing epidemics ended once the cause was understood, with parboiled rice (which retains thiamine), fortified rice, and dietary diversification eliminating beriberi as a population-scale disease in most of Asia by the mid-20th century.

Back to Table of Contents

Modern Causes

Beriberi in modern high-income countries appears in distinct clinical settings:

• Chronic alcoholism — the dominant cause in adults. Alcohol impairs intestinal thiamine absorption, accelerates urinary loss, depletes liver stores, and substitutes empty calories for thiamine-containing foods. The dry, wet, and shoshin forms all occur in alcoholic patients.
• Chronic hemodialysis — thiamine is dialyzed out of plasma each session, and dialysis patients who eat poorly are at chronic risk. Beriberi outbreaks in dialysis units have been reported.
• Bariatric surgery — particularly Roux-en-Y gastric bypass, where the jejunal absorption site is bypassed. Patients who vomit persistently after surgery or who fail to take prescribed supplements can develop beriberi within weeks to months.
• Hyperemesis gravidarum — persistent vomiting in pregnancy depletes thiamine. Wet beriberi and Wernicke encephalopathy in pregnancy have both been reported.
• Prolonged total parenteral nutrition without thiamine — the 1988 IV multivitamin shortage in the US produced a cluster of deaths from acute beriberi within weeks. The same trap recurs sporadically when generic TPN is mixed without standard additives.
• Refeeding syndrome — reintroducing carbohydrate to a severely malnourished patient depletes the already-marginal thiamine reserves and can precipitate acute beriberi or Wernicke encephalopathy. Prophylactic IV thiamine 200-300 mg/day for the first 10 days of refeeding is standard.
• Outbreaks in confined populations — immigration detention, prisons, commercial fishing vessels, refugee camps. Any homogeneous low-thiamine diet eaten for weeks can produce beriberi.
• Infantile beriberi — in breastfed infants of thiamine-deficient mothers or from defective infant formula. The 2003 Israeli soy-formula outbreak caused multiple infant deaths and permanent neurological damage in survivors.
• Heart failure on loop diuretics — furosemide and other loop diuretics accelerate urinary thiamine loss. Many heart-failure patients have a subclinical or low-grade thiamine deficiency on top of their underlying cardiac disease, and supplementation is a reasonable adjunct (see below).

Back to Table of Contents

The Biochemistry of Cardiac Failure in Thiamine Deficiency

The heart is among the most metabolically active organs per gram of tissue and depends overwhelmingly on aerobic energy production. Roughly two-thirds of cardiac ATP comes from oxidation of fatty acids and the remainder from glucose, both of which feed into the Krebs cycle through acetyl-CoA. Both pathways are blocked when thiamine pyrophosphate (TPP) becomes scarce:

• Pyruvate dehydrogenase (PDH) is blocked — glucose-derived pyruvate cannot enter the Krebs cycle and is shunted to lactate, producing the characteristic lactic acidosis.
• α-Ketoglutarate dehydrogenase is blocked — the rate-limiting step of the Krebs cycle itself fails, collapsing ATP production from both glucose and fatty acid oxidation.
• The branched-chain α-keto acid dehydrogenase (BCKDH) is also TPP-dependent and contributes a smaller fraction.

Without ATP, the cardiomyocyte cannot maintain calcium homeostasis or contractile function. The peripheral vasodilation of wet beriberi is mediated by accumulated organic acids (lactate, pyruvate) and impaired smooth-muscle metabolism. Cardiac output rises as the heart attempts to compensate; the elevated cardiac output eventually exhausts the failing cardiac reserve and overt heart failure develops.

The lactic acidosis is the diagnostic fingerprint. Few cardiac conditions produce simultaneously: high cardiac output, normal or hyperdynamic LV ejection fraction, severe lactic acidosis, and warm vasodilated peripheries. Septic shock is in the differential but lacks the hyperdynamic precordium and the chronic risk profile. The combination should prompt immediate empiric thiamine 500 mg IV.

The reversibility of cardiac dysfunction is remarkable. Within hours of parenteral thiamine, TPP is regenerated, PDH and α-KGDH reactivate, ATP production resumes, and the cardiac and vascular biochemistry normalizes. Lactate clears, cardiac output falls toward normal, edema mobilizes, and the patient improves visibly day by day.

Back to Table of Contents

Diagnosis

Beriberi is largely a clinical diagnosis based on risk factors plus phenotype. Confirmatory testing exists but is rarely available in the timeframe required for treatment decisions:

• Serum thiamine level — available at reference labs but turnaround time is 2-7 days. Useful for retrospective confirmation.
• Erythrocyte transketolase activity — the gold-standard functional marker. A baseline reading + reading after addition of TPP in vitro; an "activation coefficient" >15-20% indicates functional deficiency.
• Whole-blood thiamine pyrophosphate (TPP) by HPLC — the most accurate measure of tissue stores, but turnaround is slow.
• Serum lactate — the biochemical fingerprint of acute deficiency. Elevated lactate in a high-risk patient is a strong clue.
• Response to empirical thiamine — the most useful "test" in practice. A patient who improves dramatically within 24-72 hours of parenteral thiamine had beriberi (or Wernicke), regardless of what the lab eventually shows.

Echocardiography should be performed but is non-specific — findings range from a hyperdynamic LV with normal chamber sizes (early wet beriberi) to a dilated cardiomyopathy with biventricular dysfunction (late or shoshin). Right heart catheterization, if performed, shows high cardiac index, low systemic vascular resistance, and elevated right and left filling pressures — the classical "high-output failure" hemodynamic pattern.

The cost of empirical parenteral thiamine is trivial (the drug costs pennies; the administration costs an IV nurse minute) and the cost of missed beriberi is death. In any high-risk patient with unexplained cardiac failure, lactic acidosis, or peripheral neuropathy, give thiamine first and pursue confirmatory testing in parallel.

Back to Table of Contents

Treatment Protocol

The treatment protocol parallels that for Wernicke encephalopathy (and the two conditions often coexist, so treating one treats the other):

• Acute phase — Thiamine 500 mg IV three times daily for 3-5 days, infused in 100 mL of saline over 30 minutes per dose
• Step-down — Thiamine 250 mg IV or IM daily for an additional 3-5 days
• Maintenance — Thiamine 100 mg orally daily indefinitely (for chronic alcoholics, dialysis patients, post-bariatric patients, often for life)
• Always also — replace magnesium (essential cofactor for TPP synthesis), other B vitamins, electrolytes, and address the underlying cause (alcohol cessation, nutritional rehabilitation, surgical management of bariatric complications)

In shoshin beriberi with cardiogenic shock, thiamine takes priority over standard heart-failure therapy. Diuretics and vasopressors can worsen the situation in the absence of thiamine repletion. After thiamine is given and the cardiac biochemistry begins to recover, conventional supportive care (gentle diuresis to manage edema, vasopressors as needed for shock that does not resolve) can be added.

Magnesium replacement is critical. Thiamine cannot be converted to TPP without magnesium, and many alcoholic / malnourished patients have profound hypomagnesemia. Apparent "thiamine resistance" (failure to respond to parenteral thiamine) is often actually magnesium deficiency — check and replace magnesium aggressively.

Back to Table of Contents

Response Timeline

The response to parenteral thiamine in wet beriberi and shoshin is among the most dramatic in clinical medicine:

The speed of cardiac response is itself often considered diagnostic. A patient with refractory high-output heart failure who improves dramatically within 48 hours of parenteral thiamine had wet beriberi, regardless of what the initial lab panel showed.

Peripheral neuropathy recovers more slowly than cardiac function because nerves must physically regenerate, while cardiac muscle simply needs metabolic support restored. Sensory symptoms improve over weeks; motor strength returns over months. Severe long-standing dry beriberi may have residual deficits even with optimal treatment.

Back to Table of Contents

Heart Failure Patients on Loop Diuretics

Loop diuretics (furosemide, bumetanide, torsemide) increase urinary thiamine excretion substantially. A meaningful fraction of chronic heart failure patients on long-term loop diuretic therapy have biochemical evidence of low or borderline thiamine status, even when overt beriberi is absent.

The Schoenenberger 2012 trial randomized heart failure patients on furosemide to thiamine 300 mg/day or placebo for 28 days and found a modest but statistically significant improvement in left ventricular ejection fraction in the thiamine group. Several smaller trials have shown similar findings. The evidence is not strong enough to recommend routine thiamine supplementation for all heart failure patients, but is strong enough to recommend it for:

• Heart failure patients on high-dose loop diuretics (furosemide >80 mg/day or equivalent)
• Patients with refractory heart failure despite optimal medical therapy
• Elderly heart failure patients with poor nutritional intake
• Heart failure patients with concurrent alcohol use
• Any patient where the heart failure response to standard therapy is disappointing

A typical regimen is thiamine 100-300 mg orally daily, ideally as benfotiamine (300 mg/day) for the higher bioavailability. The cost is trivial, the safety profile is excellent, and the potential benefit is meaningful in the right patient.

Back to Table of Contents

Cautions

• Anaphylaxis with IV thiamine — rare (<1 per 5 million doses) but reported. The first IV dose should be given in a monitored setting; this does not justify withholding treatment.
• Magnesium deficiency must be corrected — thiamine cannot be converted to TPP without magnesium. Apparent "thiamine resistance" is often actually hypomagnesemia.
• Beriberi mimics other diseases — cirrhosis with ascites, septic shock, severe anemia, hyperthyroidism, and AV fistula can all produce overlapping pictures. When in doubt, give empiric thiamine while pursuing other workup.
• Standard heart-failure therapy can worsen shoshin beriberi if given before thiamine — vasopressors and aggressive diuresis can precipitate cardiovascular collapse in the volume-depleted thiamine-deficient patient.
• Glucose before thiamine is dangerous — IV dextrose in a thiamine-deficient patient can precipitate acute deterioration. Always give thiamine first or together with glucose-containing fluids.
• Long-term oral thiamine 100 mg/day is safe — thiamine is water-soluble, has no documented chronic toxicity, and is excreted in urine.
• Address the underlying cause — sustained recovery requires alcohol cessation, nutritional rehabilitation, addressing the bariatric anastomosis, treating the underlying GI disease, or whatever else drove the deficiency.

Back to Table of Contents

Key Research Papers

1. Yamasaki H et al. (2010). Acute fulminant shoshin beriberi in an alcoholic patient: case report and literature review. J Cardiol Cases. — PubMed
2. Schoenenberger AW et al. (2012). Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol. — PubMed
3. Sica DA (2007). Loop diuretic therapy, thiamine balance, and heart failure. Congest Heart Fail. — PubMed
4. Carpenter KJ (2000). Beriberi, white rice, and vitamin B: a disease, a cause, and a cure. University of California Press. — PubMed: Carpenter beriberi history
5. Fattal-Valevski A et al. (2009). Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics. — PubMed
6. Davis RE, Icke GC (1983). Clinical chemistry of thiamine. Adv Clin Chem. — PubMed
7. Brady JA et al. (1995). Thiamine status, diuretic medications, and the management of congestive heart failure. J Am Diet Assoc. — PubMed
8. Hanninen SA et al. (2006). The prevalence of thiamine deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol. — PubMed
9. Centers for Disease Control (1989). Deaths associated with thiamine-deficient total parenteral nutrition. MMWR. — PubMed
10. Donnino MW et al. (2010). Thiamine deficiency in critically ill patients with sepsis. J Crit Care. — PubMed
11. Attaluri P et al. (2018). Thiamine deficiency: an important consideration in chronic kidney disease and dialysis patients. Am J Kidney Dis. — PubMed

PubMed Topic Searches

• PubMed: beriberi thiamine deficiency
• PubMed: shoshin beriberi lactic acidosis
• PubMed: wet beriberi high-output heart failure
• PubMed: thiamine + heart failure + loop diuretic
• PubMed: infantile beriberi

Back to Table of Contents

Connections

• Vitamin B1 Overview
• B1 Benefits Hub
• B1 for Wernicke-Korsakoff
• Benfotiamine for Diabetic Neuropathy
• B1 for Cognition & Alzheimer's
• Thiamine and Beriberi
• Heart Failure
• Peripheral Neuropathy
• Diabetes
• Fatigue
• Numbness & Tingling
• Edema
• Magnesium
• ALA for Diabetic Neuropathy
• Detox Protocols
• All Vitamins

Back to Table of Contents